These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15894543)

  • 1. The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression.
    Radtke S; Haan S; Jörissen A; Hermanns HM; Diefenbach S; Smyczek T; Schmitz-Vandeleur H; Heinrich PC; Behrmann I; Haan C
    J Biol Chem; 2005 Jul; 280(27):25760-8. PubMed ID: 15894543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction.
    Haan C; Is'harc H; Hermanns HM; Schmitz-Van De Leur H; Kerr IM; Heinrich PC; Grötzinger J; Behrmann I
    J Biol Chem; 2001 Oct; 276(40):37451-8. PubMed ID: 11468294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling.
    Narazaki M; Fujimoto M; Matsumoto T; Morita Y; Saito H; Kajita T; Yoshizaki K; Naka T; Kishimoto T
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13130-4. PubMed ID: 9789053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130.
    Hilkens CM; Is'harc H; Lillemeier BF; Strobl B; Bates PA; Behrmann I; Kerr IM
    FEBS Lett; 2001 Sep; 505(1):87-91. PubMed ID: 11557047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling.
    Haque SJ; Harbor PC; Williams BR
    J Biol Chem; 2000 Aug; 275(34):26500-6. PubMed ID: 10950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.
    Haan C; Heinrich PC; Behrmann I
    Biochem J; 2002 Jan; 361(Pt 1):105-11. PubMed ID: 11742534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
    Liu KD; Gaffen SL; Goldsmith MA; Greene WC
    Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
    Kim HY; Park EJ; Joe EH; Jou I
    J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jaks and cytokine receptors--an intimate relationship.
    Haan C; Kreis S; Margue C; Behrmann I
    Biochem Pharmacol; 2006 Nov; 72(11):1538-46. PubMed ID: 16750817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new protein containing an SH2 domain that inhibits JAK kinases.
    Endo TA; Masuhara M; Yokouchi M; Suzuki R; Sakamoto H; Mitsui K; Matsumoto A; Tanimura S; Ohtsubo M; Misawa H; Miyazaki T; Leonor N; Taniguchi T; Fujita T; Kanakura Y; Komiya S; Yoshimura A
    Nature; 1997 Jun; 387(6636):921-4. PubMed ID: 9202126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational and functional analysis of the putative SH2 domain in Janus Kinases.
    Kampa D; Burnside J
    Biochem Biophys Res Commun; 2000 Nov; 278(1):175-82. PubMed ID: 11071870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.
    Radtke S; Hermanns HM; Haan C; Schmitz-Van De Leur H; Gascan H; Heinrich PC; Behrmann I
    J Biol Chem; 2002 Mar; 277(13):11297-305. PubMed ID: 11786531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
    J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase.
    Behrmann I; Smyczek T; Heinrich PC; Schmitz-Van de Leur H; Komyod W; Giese B; Müller-Newen G; Haan S; Haan C
    J Biol Chem; 2004 Aug; 279(34):35486-93. PubMed ID: 15123646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SH2-B family members differentially regulate JAK family tyrosine kinases.
    O'Brien KB; O'Shea JJ; Carter-Su C
    J Biol Chem; 2002 Mar; 277(10):8673-81. PubMed ID: 11751854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
    Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
    Mikkola ET; Gahmberg CG
    J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.